New UK CEV list identifies highest at-risk patients for COVID-19 infection

CEV - (Clinically Extremely Vulnerable)

Technically speaking, no MDS or CMML patients should have issues accessing vaccines or anti-COVID19 medication.

If however, you encounter problems, do point any GPs to the document below, which is a new list identifying exactly and precisely who the highest at risk patients are, in terms of COVID-19 infection. MDS, CMML and transplant patients are all listed.

This is the work of a new UK advisory group, supported by the NHS England RAPID-C19 team.

'The recommendations are to support the deployment of approved medications for treatment or prophylaxis, potentially across a range of scenarios.'

Access to Evushield should therefore be made available, according to the recommendations. Click below to read the report.

(Please note this CEV report is a UK only initiative.)

Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report - GOV.UK (

Free donations by shopping

Sign-up to Download our Free Patient Handbook!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

MDS UK Patient Support Group will use the information you provide on this form to be in touch with you and to provide updates.